ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MRNS Marinus Pharmaceuticals Inc

1.4099
0.0099 (0.71%)
Pre Market
Last Updated: 22:24:53
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Marinus Pharmaceuticals Inc MRNS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0099 0.71% 1.4099 22:24:53
Open Price Low Price High Price Close Price Previous Close
1.40
more quote information »

Recent News

Date Time Source Heading
15/4/202421:00BWMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE..
06/4/202407:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
27/3/202423:41BWMarinus Pharmaceuticals Comments on Patent Challenge by Ovid..
06/3/202408:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202408:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
23/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202423:00BWMarinus Pharmaceuticals to Present at Upcoming Investor..
20/2/202423:00BWMarinus Pharmaceuticals to Provide Business Update and..
17/2/202408:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
15/2/202408:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202407:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202404:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202401:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202404:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/1/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
04/1/202423:04EDGAR2Form 8-K - Current report
04/1/202423:01BWMarinus Pharmaceuticals Reports Preliminary Fourth Quarter..
08/12/202308:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/11/202323:05EDGAR2Form 8-K - Current report
21/11/202308:01BWMarinus Pharmaceuticals Announces Seven Presentations at AES..
15/11/202308:05BWMarinus Pharmaceuticals to Present at the 6th Annual..
10/11/202308:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
07/11/202323:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:11EDGAR2Form 8-K - Current report
07/11/202323:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
07/11/202323:00BWMarinus Pharmaceuticals Initiates Global Access Program for..
24/10/202322:01BWMarinus Pharmaceuticals to Provide Business Update and..
11/10/202307:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/10/202307:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/9/202321:05EDGAR2Form 8-K - Current report
22/9/202306:00BWMarinus Pharmaceuticals to Present at the 2023 Cantor Global..
19/9/202322:02EDGAR2Form 8-K - Current report
19/9/202322:00BWMarinus Pharmaceuticals Highlights Advancing Pipeline and..
13/9/202306:00BWMarinus Pharmaceuticals Announces Speakers for Hybrid..
07/9/202306:01BWMarinus Pharmaceuticals Announces Inducement Grants Under..

Your Recent History

Delayed Upgrade Clock